Not Signed In - Sangamo Receives Michael J. Fox Foundation Funding To Develop Novel ZFP Therapeutic For The Treatment Of Parkinson's Disease
Wed, 24 Jan 2007 08:00 AM EST
... Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that it has been awarded funding by The Michael J. Fox Foundation for Parkinson's Research (MJFF) to support the development of a ZFP Therapeutic(TM) to treat Parkinson's disease (PD). The $950,000 award will be paid over a period of two years. [click link for full article] ...
Related Topics
- Parkinson's Disease
- Vitiligo
- Graves' Disease
- Vascular Disease
- Parkinson disease
- Crohn's Disease
- Polycystic Kidney Disease
- Parkinson's Disease Medications
- Celiac Disease
- Periodontal Disease
- Vasculitis
- Addison's Disease
- Heart Disease
- Osteogenesis Imperfecta
- Gum Disease
- Huntington's Disease
- Hemophilia
- Confusion and changes in mental status may develop if the condition is not treated.
- Kidney Disease
- Autoimmune Diseases
email this page
print this page
bookmark this page
feedback on this page
